Hepatology Research Fellowship

id="offer-description" class="ecl-u-type-heading-2 ecl-u-mt-none ecl-u-mb-l">Offer Description The Institute for Translational Medicine and Liver Disease (ITM), Inserm U1110, University of Strasbourg France, is looking for a medical doctor to join our translational liver disease and cancer program as a physician scientist in a three-year program. The program is focussed to unravel novel strategies to treat hepatobiliary fibrosis (such as MASH and PSC) and liver cancer including hepatocellular and cholangiocarcinoma and is based on key scientific discoveries described in: Mailly et al. Nature Biotech 2015, Hamdane et al. Gastroenterology 2019, Juehling et al. Gut 2021, Crouchet et al. Nat. Commun. 2021, Roehlen et al. Science Transl. Med 2022, Roehlen et al. J. Hepatol. 2023, Del Zompo et al. J Hepatol 2025, Saviano et al. Nature Reviews Cancer 2026, Slovic et al. Hepatology 2026, Crouchet et al., JCI 2025; Nehme et al. Science Transl. Med 2026. What we offer . The institute is a world-class organisation of scientific excellence, training, and innovation in the heart of Europe within a high-quality environment of pharma, academia, and medical care. The successful candidate will benefit from: . An international and vibrant state-of-the-art training environment in biomedical research . Cutting-edge technologies including sc/snRNA and spatial transcriptomics, patient-derived models, systems biology and AI platforms . Opportunity to obtain a PhD within the U Strasbourg MD-PhD prog